Before taking on the contested cases, it is worth working the method on an easy one.
Meditation is the natural candidate. It is mainstream: studied at major universities, funded by NIH institutes, recommended in clinical guidelines for certain indications, practiced by a substantial fraction of the population. Nobody’s reputation is at risk for investigating it. And yet it presents the same core measurement problem as every other practice in this series — a subjective interior activity, undertaken for effects that participants describe in experiential language, which we would like to characterize in numbers that do not depend on the participant’s description.
If an objective endpoint cannot detect a twenty-minute meditation session, it is not going to detect anything subtler. And if it can, we learn something about what the instrument is capable of resolving, under conditions where the answer is not politically loaded.
Meditation has measurable physiological correlates. Depending on the practice and the population, studies have reported changes in heart rate variability, respiration rate and depth, skin conductance, cortisol, blood pressure, and EEG spectral distribution — particularly increased alpha and theta activity in some traditions.
So in the trivial sense, the question in the title is already answered: yes. But each of these measures comes with a complication that makes it awkward as a primary endpoint.
Heart rate variability is strongly driven by breathing rate, and most meditation instructions slow the breath. A substantial fraction of the reported HRV effect may be a respiration effect, which is interesting but is not what was claimed. Cortisol has a steep diurnal curve and responds to the experience of being in a study at all. EEG requires electrode application, has its own operator variability, and gives a signal that is arguably closer to the practice than to its physiological consequences. Blood pressure is coarse. Self-report is disqualified for reasons covered in the pillar post.
None of this makes these measures useless. It means the field would benefit from an additional endpoint with different failure modes — one that is not obviously confounded by breathing, is fast enough to capture a twenty-minute window, and is low-burden enough to be repeated many times.
A serious version of the study would be within-subject, and would spend most of its effort on things that are not the meditation.
The first phase measures nothing but the instrument. Participants arrive, sit quietly, and are scanned repeatedly at the intervals the protocol will later use — same room, same posture, same time of day, no intervention of any kind. This establishes the measurement’s own variability across a session, which is the number every subsequent result will be compared against. It is unglamorous and it is the single most important part of the design. A change score means nothing without it.
The second phase introduces conditions in randomized order across sessions: meditation, and at least one active control. The active control is what separates a meaningful result from a trivial one. Twenty minutes of quiet sitting with eyes closed will produce physiological change on its own — so will twenty minutes of an audiobook, or twenty minutes of paced breathing without any meditative component. A study that compares meditation to nothing establishes only that sitting still does something. A study that compares meditation to paced breathing and to quiet rest is asking whether the practice contributes anything beyond its components, which is the actual question.
The primary endpoint is named in the pre-registration before the first participant sits down. The analyst receives condition labels they cannot decode.
Suppose the study runs and the meditation condition produces a change that is reliably distinguishable from both control conditions, in the pre-specified metric, at adequate power.
That would establish that the instrument detects a physiological difference associated with the practice, over and above posture, stillness, and breathing pattern. It would characterize the size of that difference and the time course over which it appears and decays. It would give a variance estimate for designing subsequent studies. That is a genuinely useful result and, importantly, a replicable one — another group could attempt exactly the same thing.
It would not establish that meditation is beneficial. A measurable change is not a good change; the relationship between any physiological metric and any health outcome is a separate empirical question requiring separate, and much longer, studies. It would not establish a mechanism. It would not tell you which meditation practice, for which population, or for how long.
And a null result would be equally informative, provided the instrument-characterization phase was done properly. “This endpoint does not resolve a change of this size on this timescale” is a real finding about the instrument, and it would tell us to stop proposing it for harder questions.
Because the method should be established where the stakes are low.
If we ran this design first on an intention-based modality, every element of it — the control arms, the endpoint, the variance estimate, the analysis plan — would be scrutinized as though it had been chosen to produce a particular answer. Running it first on meditation, where no one has a stake, produces a validated protocol and a characterized instrument that can then be carried, unchanged, into contested territory.
That is not a rhetorical strategy. It is what calibration is for.
Regulatory note: Aurorus is a non-invasive electrophysiological measurement platform. It was granted FDA De Novo classification (DEN150004) as a Class I non-invasive electrophysiological measurement device. It is not cleared for diagnostic purposes. Nothing in this article claims that any therapy, modality, or practice diagnoses, treats, cures, or prevents any disease.